Geographic Atrophy Due to Age-related Macular Degeneration
📧 Sign up to get email alerts when something new happens for Geographic Atrophy Due to Age-related Macular Degeneration.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Development and Evaluation of Functional Visual Field and Navigation Endpoints in Moderate to Profound Inherited Retinal Disease (DEFINE-IRD)
Clinical trial update on the development and evaluation of functional visual field and navigation endpoints for moderate-to-profound inherit…
-
FDA approval · 2023-08-04FDA Approved: IZERVAY — Original Application (Astellas Pharma US, Inc.)
FDA approved IZERVAY (avacincaptad pegol) from Astellas for geographic atrophy due to age-related macular degeneration.
-
CLINICAL_TRIALS trial_result · 2013-04-26Clinical Trial Update: Safety and Efficacy of Brimonidine Intravitreal Implant in Patients With Geographic Atrophy Due to Age-related Macular Degeneration (AMD) [Phase 2]
Phase 2 trial update on safety and efficacy of brimonidine intravitreal implant for geographic atrophy due to age-related macular degenerati…